Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $0.5814, but opened at $0.5963. Elite Pharmaceuticals shares last traded at $0.5743, with a volume of 198,149 shares changing hands.
Elite Pharmaceuticals Stock Performance
The business’s fifty day moving average is $0.63 and its two-hundred day moving average is $0.60. The stock has a market capitalization of $592.61 million, a PE ratio of -55.20 and a beta of 0.10. The company has a quick ratio of 5.44, a current ratio of 7.23 and a debt-to-equity ratio of 0.09.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Recommended Stories
- Five stocks we like better than Elite Pharmaceuticals
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why a 20-Second Flight Test Could Unlock Billions for Vertical
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Smart Defensive Stocks for an Uneasy Market
- What is a Low P/E Ratio and What Does it Tell Investors?
- These 3 Stocks Are Using Buybacks to Signal Market Confidence
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
